Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Department of Biomedical Engineering, Sichuan University Library, Chengdu, 610041, Sichuan, China.
Eur Arch Otorhinolaryngol. 2024 Aug;281(8):3959-3975. doi: 10.1007/s00405-024-08577-1. Epub 2024 Apr 22.
We performed this systematic review and meta-analysis to explore the impact of preoperative sarcopenia on postoperative complication risks after head and neck cancer (HNC) surgery.
We identified eligible studies by searching Ovid-MEDLINE, Ovid-Embase, EBM Reviews-Cochrane Central Register of Controlled Trials, Web of Science Core Collection, and Scopus. This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance.
Twenty-one studies with a total of 3480 patients met our inclusion criteria. The presence of sarcopenia significantly increased the incidence of overall postoperative complications (OR = 1.72, 95% CI 1.23, 2.41; P = 0.002; I = 59%). Subgroup analyses showed a higher risk of postoperative complications in the populations in which sarcopenia was diagnosed with low L3-skeletal muscle index (L3-SMI) or low cross-sectional area of the rectus femoris, but not in the group that sarcopenia was diagnosed with low C3-SMI. Preoperative sarcopenia also substantially increased the risk of severe postoperative complications (OR = 2.26), pharyngocutaneous fistulas (OR = 2.15), free flap-related complications (OR = 1.63), and surgical site infections (OR = 1.84). We also found a tendency toward a higher incidence of wound complications and 30-day mortality in patients with sarcopenia.
Preoperative sarcopenia is a negative prognostic indicator for postoperative complications in patients with HNC after surgery. To reduce the incidence of postoperative complications and improve poor prognosis, further attention needs to be paid to the evaluation and management of preoperative sarcopenia.
本系统评价和荟萃分析旨在探讨术前肌少症对头颈癌(HNC)术后术后并发症风险的影响。
我们通过搜索 Ovid-MEDLINE、Ovid-Embase、EBM Reviews-Cochrane 中心对照试验注册库、Web of Science 核心合集和 Scopus 来确定符合条件的研究。本系统评价按照系统评价和荟萃分析的首选报告项目进行。
符合纳入标准的 21 项研究共有 3480 例患者。肌少症的存在显著增加了总体术后并发症的发生率(OR=1.72,95%CI 1.23,2.41;P=0.002;I=59%)。亚组分析显示,在肌少症诊断为低 L3 骨骼肌指数(L3-SMI)或低股直肌横截面积的人群中,术后并发症风险较高,但在肌少症诊断为低 C3-SMI 的人群中,风险并未增加。术前肌少症也显著增加了严重术后并发症(OR=2.26)、咽瘘(OR=2.15)、游离皮瓣相关并发症(OR=1.63)和手术部位感染(OR=1.84)的风险。我们还发现肌少症患者的伤口并发症和 30 天死亡率也有升高的趋势。
术前肌少症是 HNC 患者手术后术后并发症的不良预后指标。为了降低术后并发症的发生率,改善不良预后,需要进一步关注术前肌少症的评估和管理。